Weiss Asset Management LP

Related company / holding

Enjoy Technology, Inc./deAvadel Pharmaceuticals PLCPfenex Inc.Theravance Biopharma, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 1 saleMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (3 ops.)

€198.9M

Latest filing published 28 Sept 2026 for Theravance Biopharma, Inc., €110.8M.

Filing timeline

BuySale

Weiss Asset Management LP

Insider track record

Disclosed buys

Disclosed sells

Signal history

Weiss Asset Management LP: trading record in brief

Weiss Asset Management LP is a declared insider at 4 companies; the most frequent names are Pfenex Inc., Avadel Pharmaceuticals PLC and Enjoy Technology, Inc./de. The record holds 5 filings, for trades running from 29 September 2020 to 23 September 2026.

Every open-market trade on record is a sale: 3 sales worth €198.9M. Since January 2026: no purchases and 1 sale on the market.

Most recently, on 28 September 2026, the filings show a transaction worth €110.8M in Theravance Biopharma, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.